MANE Latest Press Releases

-- October 19, 2026 --

Veradermics' Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 '304' Clinical Trial in Male Pattern Hair Loss Business Wire 7:00 AM

-- October 18, 2026 --

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 3 '304' Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss Business Wire 6:00 PM

-- September 3, 2026 --

Veradermics to Present at Upcoming September Investor Conferences Business Wire 5:33 PM

-- August 11, 2026 --

Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress Business Wire 7:30 AM

-- July 17, 2026 --

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study '302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy Business Wire 7:30 AM

-- July 15, 2026 --

Veradermics' Oral VDPHL01 Delivers Positive Study '207' Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study '306' Readout Business Wire 7:00 AM

-- July 14, 2026 --

Veradermics to Hold Conference Call to Discuss Study '207' Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss Business Wire 6:54 PM

-- June 2, 2026 --

Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors Globe Newswire 8:30 AM

-- May 28, 2026 --

Veradermics to Present at Upcoming June Investor Conferences Business Wire 4:30 PM

-- May 27, 2026 --

Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 '302' Study of VDPHL01 at the 2026 World Congress for Hair Research Business Wire 7:30 AM

Market Data Delayed 15 Minutes